Faculty Affairs News Supporting and Celebrating Faculty Success at UTMB
A Message from the Senior Vice President and Provost (interim):
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Highlights from Around Our Schools
New Grants
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Events
News and Awards
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
The Office of Innovation and Commercialization will host an immersive Summer Camp focused on innovation and entrepreneurship in the health and life science.
Research Day, to be held May 29, is presented by the Council of Vice Chairs for Research. Research Day 2025 will feature a poster forum highlighting the best of UTMB’s current research as well as the popular Core Showcase.
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
This in-person, six-hour, evidence-based workshop helps develop skills and insights in mentoring through interactions and discussions.
Do you have an item for our Faculty Affairs newsletter? Please provide your submissions by May 20 to be considered for publication in the next edition.
